Adhesion Barrier return on investment

INVESTORS BEWARE!

As IHRT contemplates the desperation of consumers to have adhesion barriers provided in their surgeries and industries willingness to provide them, we are disheartened.
Patients aware of adhesion barriers or indeed adhesions are a slim minority.
Adhesion Barrier Market to Skyrocket to Over $550 Million by 2013PR Newswire (press release), NY - Feb 2, 20092 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers 2009 ...
As we reflect on this headline, one wonders where this number comes from?
IHRT then looks at the source of this press release.
IRONICALLY, Millennium Research Group is based in Waltham, MA, home of Confluent SprayGel and SprayShield !
If an effective adhesion barrier were found and put into use….the number would be enormous!
Here is an example of a guess on what that number might truly be.
_____
Cesarean Fact Sheet - Childbirth.org
Some facts about cesarean sections from Childbirth.org. ... The latest statistics indicate that 967000 cesareans were performed in the US in 1989. ...www.childbirth.org/section/CSFact.html - 16k - Cached - Similar pages
_______
Lets say each of these c-sections had and adhesion barrier applied at the cost of $200.00 per procedure. We feel that this would be a very conservative estimate. The cost would be $193,400,000 for just one procedure in which the number of c-section has increased dramatically since this statistic was reported…
Take the history of Spraygel to it’s current incarnation as SprayShield TM.
All IHRT can think to say is, “return on investment”.
Here is an example to see.
_____
Tuesday, October 28, 2008
Falling apart over Omrix
When I added Omrix Biopharmaceuticals Ltd. (Nasdaq:OMRI) to my portfolio, tracked by "Globes", I noted that it was a profitable biotechnological company in a most interesting niche - biosurgical sealants for the prevention of hemostasis in surgery - and that it was not an all or nothing company, like Pharmos Corp. (Nasdaq: PARSD), for example, where one failed trial can wipe almost an entire investment.
_____________
The founder of Confluent Surgical knew his product would not pass FDA standards so the product was taken out of clinical trials….
Somehow, with fraudulent information SprayGel got it’s CE mark and was used throughout the world as an anti-adhesion barrier. Those in the United States remained safe.
IHRT was founded by the victims of ongoing study of Spraygel until we realized we were being experimented on and paying for the pleasure. In of all places Germany!
The gig was up and Confluent was sold to Tyco which was then sold to Covidien.
As IHRT continues to watch Covidiens stocks fall we become more concerned about them seeking a quick return on their investment!
_____
Top of Form
COV (Common Stock)
Exchange
NYSE(US Dollar)
Price
$34.46
Change (%)
0.69 (1.96%)
Volume
1,019,293
As of 02/26/09 11:23 a.m. ETMinimum 20 minute delay
Bottom of Form
http://investor.covidien.com/preview/phoenix.zhtml?c=207592&p=irol-alerts
_____
It looks like Covidien may have learned to save money by moving it all offshore just as Confluent did.
Is it the old lets see if it works ON THEM and then go to the FDA?
The same scenario is happening again with of all people, Kruschinski and Mettler. In of all places Germany!
http://www.or-live.com/covidien/2457/Pre-clinical%20Data.pdf
Kruschinski D, Homburg S, D’Souza F, Campbell P, Reich H.
Adhesiolysis in severe and reccurent cases of adhesions related
disorder (ARD) - a novel approach utilizing lift (gasless)
laparoscopy and SprayGel™ adhesion barrier. Surg Technol Int.
2006;15:131-9.

Mettler L, Audebert A, Lehmann-Willenbrock E, Schive-Peterhansl
K, Jacobs VR. A randomized, prospective, controlled,
multicenter clinical trial of a sprayable, site-specific adhesion
barrier system in patients undergoing
______
Somehow the bogus science in the above studies are being used once again to tout a product and way after the fact are we learning how the bogus studies of SprayGel made thing worse for us for all of us. Victims of this fraud would tell you there are things worse than death....

It is IHRT’s opinion that until there are actually surgeons learned enough to perform an adhesiolysis that needs no barrier, these products are just a panacea…

Skill is what’s needed and compensation for the time it takes to perform a successful adhesiolyis.
Until then we fell everyone’s just kidding themselves and no product can compensate for, quick or ultra conservative surgery.
So think hard and do your research, be careful of patients who claim this is the best or only way.
_____
...and then you have Karen Steward!!!! Beware!
How many doctors (surgeons) encourage those who are sick to contact his former patients? No doubt, Dr. Kruschinski has raised the bar of excellence when it comes to "treating" a patient. See: Patient List

Thanks Dr. Kruschinski. Our daughter has regained her life due to your brilliance, commitment and compassion for those who suffer from this dread disorder.
http://www.adhesionpain.net/2008/09/five-yearsthank.html

This is what IHRT calls “Harvesting” a dreadful practice that can lead a person to an unwanted intervention.
_____
Remember that these biomedical companies and surgeons are expecting a return on their investments and patients are a dime a dozen. We must remember always “people are willing to profit from others pain”. Our capitulation to the adhesion barrier craze just seems to make us “a return on investment”